Literature DB >> 8651123

Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

M A Munger1, B Johnson, I J Amber, K S Callahan, E M Gilbert.   

Abstract

Proinflammatory cytokines are capable of modulating cardiovascular function by a variety of mechanisms. These cytokines are elevated in patients with severe heart failure, but changes in mild or moderate heart failure have not been reported. Therefore, simultaneous arterial and coronary sinus concentrations of interleukin-1alpha, soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha were measured in 78 patients with New York Heart Association functional class II to IV heart failure and compared with 17 healthy volunteers. Concentrations of interleukin-1alpha, soluble interleukin-2 receptor, and interleukin-6 were determined by a "sandwich" enzyme-linked immunosorbent assay and tumor necrosis factor-alpha by tissue culture technique. There were no statistical differences in interleukin-1alpha, soluble interleukin-2 receptor, or tumor necrosis factor-alpha concentrations in mild to moderate heart failure versus control subjects. Interleukin-6 was significantly elevated, 75 +/- 16 versus 0.4 +/- 0.4pg/ml (p = 0.002). Cytokine concentrations did not differ by heart failure etiology. Paired arterial and coronary sinus concentrations were not significantly different. Soluble interleukin-2 receptor concentrations were significantly correlated with New York Heart Association functional class (r = 0.59, p = 0.04) and negatively associated with exercise tolerance time (r = -0.59, p = 0.007). Thus, interleukin-6 is significantly elevated in mild or moderate heart failure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651123     DOI: 10.1016/s0002-9149(97)89206-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  45 in total

Review 1.  Activation of cytokines as a mechanism of disease progression in heart failure.

Authors:  B Bozkurt
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  Effects of telmisartan on markers of ventricular remodeling in patients with acute myocardial infarction: comparison with enalapril.

Authors:  Takashi Yokota; Tomohiro Osanai; Kenji Hanada; Motoi Kushibiki; Naoki Abe; Koichi Oikawa; Hirofumi Tomita; Takumi Higuma; Jin Yokoyama; Hiroyuki Hanada; Ken Okumura
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

3.  Circulating interleukin-6 significantly correlates to thyroid hormone in acute myocardial infarction but not in chronic heart failure.

Authors:  M Nishino; T Kimura; T Kanda; N Kotajima; A Yoshida; A Kuwabara; K Tamama; Y Fukumura; I Kobayashi
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

Review 4.  Reversal of maladaptive gene program in left ventricular myocardium of dogs with heart failure following long-term therapy with the Acorn Cardiac Support Device.

Authors:  Sharad Rastogi; Sudhish Mishra; Ramesh C Gupta; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

Review 5.  Neurohormonal modulation in heart failure of ischemic etiology: correlates with left ventricular remodeling.

Authors:  Roberto Latini; Serge Masson; Lidia Staszewsky; Simona Barlera
Journal:  Curr Heart Fail Rep       Date:  2006-12

6.  Relation between red cell distribution width and clinical outcome after surgery for congenital heart disease in children.

Authors:  Martial M Massin
Journal:  Pediatr Cardiol       Date:  2012-10       Impact factor: 1.655

7.  Systemic levels of G-CSF and interleukin-6 determine the angiogenic potential of bone marrow resident monocytes.

Authors:  Alyssa D Gregory; Benjamin J Capoccia; Jill R Woloszynek; Daniel C Link
Journal:  J Leukoc Biol       Date:  2010-03-30       Impact factor: 4.962

Review 8.  Immune modulation in heart failure: past challenges and future hopes.

Authors:  Jose H Flores-Arredondo; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 9.  Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications.

Authors:  A P Bolger; S D Anker
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

10.  The role of exercise on L-arginine nitric oxide pathway in chronic heart failure.

Authors:  A C Mendes-Ribeiro; G E Mann; L R de Meirelles; M B Moss; C Matsuura; T M C Brunini
Journal:  Open Biochem J       Date:  2009-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.